{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:41:16Z","timestamp":1785235276955,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/J00751X\/1"],"award-info":[{"award-number":["BB\/J00751X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025292","name":"Xjenza Malta","doi-asserted-by":"publisher","award":["CRP-2024-002"],"award-info":[{"award-number":["CRP-2024-002"]}],"id":[{"id":"10.13039\/501100025292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ab.2025.116033","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:55:39Z","timestamp":1765814139000},"page":"116033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Towards canine immunotherapy models: Monoclonal antibodies with redox regulated epitopes targeting TIM3 attenuate Galectin-9 binding"],"prefix":"10.1016","volume":"711","author":[{"given":"Jack","family":"Brydon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radovan","family":"Krejcir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Grima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Zavadil-Kokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6040-823X","authenticated-orcid":false,"given":"Zuzana","family":"Kuncova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sousan","family":"Sousan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"Pflughaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Argyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borivoj","family":"Vojtesek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-0352","authenticated-orcid":false,"given":"Ted","family":"Hupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Parys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2025.116033_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ab.2025.116033_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2011.12.004","article-title":"Inflammation and immune surveillance in cancer","volume":"22","author":"Chow","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ab.2025.116033_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2019.11.010","article-title":"Promising approaches in cancer immunotherapy","volume":"225","author":"Taefehshokr","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.ab.2025.116033_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ijc.35156","article-title":"The future of immunotherapy for diffuse large B-cell lymphoma","volume":"156","author":"Duell","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ab.2025.116033_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ab.2025.116033_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B cell responses: cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ab.2025.116033_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-018-0001-y","article-title":"The full spectrum of human naive T cells","volume":"18","author":"van den Broek","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ab.2025.116033_bib8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.cell.2022.02.012","article-title":"Tumor-reactive antibodies evolve from non-binding and autoreactive precursors","volume":"185","author":"Mazor","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ab.2025.116033_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/bs.acr.2019.03.003","article-title":"Co-stimulatory and co-inhibitory pathways in cancer immunotherapy","volume":"143","author":"O'Neill","year":"2019","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ab.2025.116033_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12026-014-8524-1","article-title":"Regulation of T cell responses by the receptor molecule Tim-3","volume":"59","author":"Gorman","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ab.2025.116033_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.immuni.2024.01.010","article-title":"LAG-3, TIM-3, and TIGIT: distinct functions in immune regulation","volume":"57","author":"Joller","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.ab.2025.116033_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ab.2025.116033_bib13","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1042\/BCJ20210425","article-title":"Phosphatidylserine binding directly regulates TIM-3 function","volume":"478","author":"Smith","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.ab.2025.116033_bib14","article-title":"Interaction of the immune system TIM-3 protein with a model cellular membrane containing phosphatidyl-serine lipids","volume":"30","author":"Delova","year":"2024","journal-title":"Chemistry"},{"key":"10.1016\/j.ab.2025.116033_bib15","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo Pulido","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ab.2025.116033_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature13848","article-title":"CEACAM1 regulates TIM-3-mediated tolerance and exhaustion","volume":"517","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ab.2025.116033_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115445","article-title":"Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases","volume":"209","author":"Bailly","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ab.2025.116033_bib18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ab.2025.116033_bib19","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection","volume":"205","author":"Jones","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ab.2025.116033_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ab.2025.116033_bib21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","article-title":"TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells","volume":"7","author":"Kikushige","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ab.2025.116033_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030645","article-title":"TIM-3 as a target for cancer immunotherapy and mechanisms of action","volume":"18","author":"Du","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ab.2025.116033_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molimm.2023.03.008","article-title":"Gal-9\/Tim-3 signaling pathway activation suppresses the generation of Th17 cells and promotes the induction of Foxp3(+) regulatory T cells in renal ischemia-reperfusion injury","volume":"156","author":"Wang","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ab.2025.116033_bib24","article-title":"Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ab.2025.116033_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2021.04.011","article-title":"The TIM3\/Gal9 signaling pathway: an emerging target for cancer immunotherapy","volume":"510","author":"Kandel","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ab.2025.116033_bib26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-020-0297-3","article-title":"Improving human cancer therapy through the evaluation of pet dogs","volume":"20","author":"LeBlanc","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ab.2025.116033_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010223","article-title":"Anti-PD-1 and novel combinations in the treatment of Melanoma-An update","volume":"9","author":"Gellrich","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ab.2025.116033_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1013270","article-title":"Barking up the right tree: immune checkpoint signatures of human and dog cancers","volume":"21","author":"Kocikowski","year":"2025","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ab.2025.116033_bib29","article-title":"The development of a canine single-chain phage antibody library to isolate recombinant antibodies for use in translational cancer research","volume":"5","author":"Lisowska","year":"2025","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.ab.2025.116033_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nprot.2009.182","article-title":"Nonlinear least-squares data fitting in excel spreadsheets","volume":"5","author":"Kemmer","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ab.2025.116033_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206427","article-title":"The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells","volume":"13","author":"Schott","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ab.2025.116033_bib32","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.tibtech.2021.03.003","article-title":"Animal immunization, in vitro display technologies, and machine learning for antibody discovery","volume":"39","author":"Laustsen","year":"2021","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ab.2025.116033_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jmb.2004.01.017","article-title":"Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein","volume":"337","author":"Burch","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ab.2025.116033_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pro.2439","article-title":"Over-expression of secreted proteins from mammalian cell lines","volume":"23","author":"Dalton","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.ab.2025.116033_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2287250","article-title":"Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors","volume":"15","author":"Yoshimoto","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.ab.2025.116033_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ab.2025.116033_bib37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ab.2025.116033_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-022X(03)00145-3","article-title":"Determination of antibody affinity by ELISA. Theory","volume":"57","author":"Bobrovnik","year":"2003","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.ab.2025.116033_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jim.2009.10.002","article-title":"Comparison of the results obtained by ELISA and surface plasmon resonance for the determination of antibody affinity","volume":"352","author":"Heinrich","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ab.2025.116033_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75533-4","article-title":"A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs","volume":"10","author":"Igase","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ab.2025.116033_bib41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1126\/science.1157533","article-title":"Censoring of autoreactive B cell development by the pre-B cell receptor","volume":"321","author":"Keenan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ab.2025.116033_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vetimm.2010.07.026","article-title":"Generation and validation of canine single chain variable fragment phage display libraries","volume":"139","author":"Braganza","year":"2011","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ab.2025.116033_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2010.08.009","article-title":"Isolation of a human anti-epidermal growth factor receptor fab antibody, EG-19-11, with subnanomolar affinity from naive immunoglobulin repertoires using a hierarchical antibody library system","volume":"134","author":"Hur","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ab.2025.116033_bib44","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1172\/JCI109996","article-title":"Disulfide reduction converts the insulin receptor of human placenta to a low affinity form","volume":"66","author":"Jacobs","year":"1980","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ab.2025.116033_bib45","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/protein\/14.9.691","article-title":"Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides","volume":"14","author":"Coley","year":"2001","journal-title":"Protein Eng."},{"key":"10.1016\/j.ab.2025.116033_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/bioinformatics\/btv522","article-title":"Hammock: a hidden Markov model-based peptide clustering algorithm to identify protein-interaction consensus motifs in large datasets","volume":"32","author":"Krejci","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ab.2025.116033_bib47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.molimm.2019.09.014","article-title":"B-cell epitopes: discontinuity and conformational analysis","volume":"114","author":"Ferdous","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ab.2025.116033_bib48","article-title":"Structural features of antibody-peptide recognition","volume":"13","author":"Lee","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ab.2025.116033_bib49","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.2004638","article-title":"Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors","volume":"13","author":"Mason","year":"2021","journal-title":"mAbs"},{"key":"10.1016\/j.ab.2025.116033_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110863","article-title":"Validation of a PD-1\/CD28 chimeric switch receptor to augment CAR-T function in dogs with spontaneous B cell lymphoma","volume":"27","author":"Yoshimoto","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ab.2025.116033_bib51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molimm.2013.11.001","article-title":"The Tim-3\/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis","volume":"58","author":"Ju","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ab.2025.116033_bib52","first-page":"227","article-title":"A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy","volume":"3","author":"Kuang","year":"2020","journal-title":"Antib. Ther."},{"key":"10.1016\/j.ab.2025.116033_bib53","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1158\/1078-0432.CCR-25-0806","article-title":"Combined targeting of PD-1 and TIM-3 in patients with locally advanced or metastatic non-small cell lung cancer: AMBER part 2B","volume":"31","author":"Davar","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ab.2025.116033_bib54","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cell.2018.12.034","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"176","author":"Sade-Feldman","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ab.2025.116033_bib55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature04338","article-title":"Genome sequence, comparative analysis and haplotype structure of the domestic dog","volume":"438","author":"Lindblad-Toh","year":"2005","journal-title":"Nature"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269725002726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269725002726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:26:43Z","timestamp":1773959203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269725002726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":55,"alternative-id":["S0003269725002726"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2025.116033","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards canine immunotherapy models: Monoclonal antibodies with redox regulated epitopes targeting TIM3 attenuate Galectin-9 binding","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2025.116033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116033"}}